Related Articles Esophageal stenting for benign and malignant disease: European Society of Gastrointestinal Endoscopy (ESGE) Clinical Guideline. Endoscopy. 2016 Oct;48(10):939-48 Authors: Spaander MC, Baron TH, Siersema PD, Fuccio L, Schumacher B, Escorsell À, Garcia-Pagán JC, Dumonceau JM, Conio M, de Ceglie A, Skowronek J, Nordsmark M, Seufferlein T, Van Gossum A, Hassan C, Repici A, Bruno MJ Abstract This Guideline is an official statement of the European Society of Gastrointestinal Endoscopy (ESGE), endorsed by the European Society for Radiotherapy and Oncology (ESTRO), the European Society of Digestive Endoscopy (ESDO), and the European Society for Clinical Nutrition and Metabolism (ESPEN). The…
Origen: Esophageal stenting for benign and malignant disease: European Society of Gastrointestinal Endoscopy (ESGE) Clinical Guideline. – PubMed

Related Articles [The special requirements of old age in terms of dying]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2017 Jan;60(1):18-25 Authors: Kruse A Abstract It is expected that the rising average life expectancy will leave ever more people with chronic progressive diseases of the body and brain. This then means not only having to deal with increasingly longer periods of care, but also possibly distinct neurocognitive disorders in the years prior to death and dying. The aim of this study is to report epidemiological data on the causes of death, as well as on the places of death. In addition, the attitudes and…
Origen: [The special requirements of old age in terms of dying]. – PubMed

Related Articles Use of palliative chemotherapy in patients aged 80 years and over with incurable cancer: experience at three Sydney cancer centres. Intern Med J. 2017 Jan;47(1):75-81 Authors: Ip E, Pokorny AM, Della-Fiorentina S, Beale P, Bray V, Kiely BE, Blinman P Abstract BACKGROUND: Octogenarians represent a growing population reviewed in medical oncology clinics, yet there is a paucity of data on how chemotherapy is tolerated in this age group. AIM: To describe the use of palliative first-line chemotherapy in patients 80 years and over and factors associated with its use. METHODS: We identified all new patients aged 80 years…
Origen: Use of palliative chemotherapy in patients aged 80 years and over with incurable cancer: experience at three Sydney cancer centres. – PubMed

Related Articles Unanticipated Readmissions During the Interstage Period in Patients With Hypoplastic Left Heart Syndrome: Can the Numbers be Safely Reduced? Semin Thorac Cardiovasc Surg. 2016;28(4):815-816 Authors: Tabbutt S, Ghanayem N PMID: 28417869 [PubMed – indexed for MEDLINE]
Origen: Unanticipated Readmissions During the Interstage Period in Patients With Hypoplastic Left Heart Syndrome: Can the Numbers be Safely Reduced? – PubMed

Related Articles Subnormal vision device augmenting palliative treatment of hypertension; a case report. Am J Optom Arch Am Acad Optom. 1949 May;26(5):212-4 Authors: FRIEDENBERG HL PMID: 18131742 [PubMed – indexed for MEDLINE]
Origen: Subnormal vision device augmenting palliative treatment of hypertension; a case report. – PubMed